111
Participants
Start Date
October 31, 2010
Primary Completion Date
August 31, 2011
Study Completion Date
August 31, 2011
Difluprednate 0.05% ophthalmic emulsion
1 drop in study eye, 4 times a day, for 14 days, followed by a 14-day tapering period dependent on the Investigator's determination of adequate response to treatment
Prednisolone acetate 1.0% ophthalmic suspension
1 drop in study eye, 8 times a day, for 14 days, followed by a 14-day tapering period dependent on the Investigator's determination of adequate response to treatment
Contact Alcon Call Center, Fort Worth
Lead Sponsor
Alcon Research
INDUSTRY